P2-156: Effects of collagen IV on cisplatin-induced apoptosis of non-small cell lung cancer cells

Caicun Zhou,Chunxia Su,Bo Su

DOI: https://doi.org/10.1097/01.JTO.0000283620.54038.2c

IF: 20.121

2007-01-01

Journal of Thoracic Oncology

Abstract:Most lung cancer patients cannot be cured with current therapeutic modalities. Drug resistance is one of the major causes in treatment failure of non-small cell lung cancer {NSCLC). Classical drug resistant mechanisms have been elucidated upon monocellular models. However, these models do not consider the tumor microenvironment in vivo. Recently, interactions between the tumor cells and extracellular matrix (ECM) have been shown to be one of the mechanisms of drug resistance. We investigated effects of ECM on cisplatin-induced apoptosis of the cell line A549 and cisplatin-resistant cell line A549-DDP, and the role of phosphatidylinositol 3'-kinase(PI3-K) in ECM's signal pathway. A549 and A549-DDP cells were cultured in RPMI 1640 supplemented with 10% fetal calf serum in vitro, 6 μmol/L cisplatin (DDP)was added to maintain the drug resistant phenotype of the A549-DDPcells. The inhibitory effects of DDP and/or LY294002 (PI3-K inhibitor) on cellular proliferation were tested by methabenzthiazuron (MTT) assay. Immunocytochemistry was used to detect the expression of extracellular matrix and integrin β1 of these two cell lines, respectively. Cell adhesion experiments were used to test cell adhesion rates. Flow cytometry was applied to study the influence of collegen IV (C IV) and LY294002 on A549/DDP cells' apoptosis and cell cycle distribution before and after DDP treatment. The expression of ECM proteins in cisplatin-sensitive and cisplatin-resistance lung cancer cells were different. Extracellular matrix Cmediated cell adhesion promotes survival of A549 and A549-DDP cells from cisplatin insults. Pre-coating with collagen IV protect non-small cell lung cancer cells from drug-induced growth inhibition, which is PI 3-kinase/Akt-dependent. Combining cisplatin with LY294002 caused greater increases in apoptosis compared with that caused by the inhibitor or cisplatin alone. Collagen IV changed A549 cells cell cycle distribution, with an increase in G1 phase, a reduction in S and G2/M phases, as treated with cisplatin or combined with LY294002. After being infected with dominant-negative forms of integrin β1 plasmid, both of these two cell lines can become relatively sensitive to cisplatin. ECM may provide protection against cisplatin-induced apoptosis of A549 and A549-DDP cells, while LY294002 increases the growth inhibitory effect of cisplatin. Integrin &β1 signaling and PI3-Kinase pathway may be important survival pathways of drug-induced apoptosis in lung cancer cells and activation of this pathway may contribute to the generation of drug resistance.